Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RANIMUSTINE for Central nervous system lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where RANIMUSTINE was used for Central nervous system lymphoma.

Most Reported Side Effects for RANIMUSTINE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 25 11.4% 8 7
Drug ineffective 24 10.9% 7 10
Haemolytic anaemia 16 7.3% 0 15
Thrombotic microangiopathy 16 7.3% 0 15
Hepatitis b 14 6.4% 2 0
Hypoxia 14 6.4% 0 11
Ventricular hypokinesia 14 6.4% 0 13
Acute kidney injury 13 5.9% 0 11
Bone marrow failure 12 5.5% 1 5
Cardiac failure 12 5.5% 0 11
Renal impairment 12 5.5% 1 2
Acute myeloid leukaemia 11 5.0% 9 1
Hypertension 11 5.0% 0 8
Myelodysplastic syndrome 11 5.0% 0 0
Myelosuppression 11 5.0% 0 8

Other Indications for RANIMUSTINE

Adult t-cell lymphoma/leukaemia (55) Diffuse large b-cell lymphoma (39) Bone marrow conditioning regimen (17) Plasma cell myeloma (13) Product used for unknown indication (8) Hodgkin's disease (7) Non-hodgkin's lymphoma (7) Lymphoma (5)

Other Drugs Used for Central nervous system lymphoma

METHOTREXATE (2,075) RITUXIMAB (1,714) CYTARABINE (843) VINCRISTINE (551) IBRUTINIB (421) TEMOZOLOMIDE (402) THIOTEPA (396) IFOSFAMIDE (394) PROCARBAZINE (365) ETOPOSIDE (335)

Related Pages

RANIMUSTINE Full Profile All Central nervous system lymphoma Drugs RANIMUSTINE Demographics RANIMUSTINE Timeline